ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
34.74
+0.37 (1.08%)
Jun 30, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.62 billion as of July 1, 2026. Its market cap has increased by 103.24% in one year.
Market Cap
1.62B
Enterprise Value
1.29B
1-Year Change
103.24%
Ranking
Category
Stock Price
$34.74
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.62B, an increase of 181.29%. That is a compound annual growth rate of 53.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 1.62B | 94.80% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.66B |
| Fortrea Holdings | 1.66B |
| Maravai LifeSciences Holdings | 1.65B |
| MoonLake Immunotherapeutics | 1.64B |
| Zenas BioPharma | 1.61B |
| Maze Therapeutics | 1.61B |
| Ascentage Pharma Group International | 1.58B |
| Septerna | 1.57B |